Becker's Healthcare June 14, 2024
Rylee Wilson

Around 1 in 3 employers covered GLP-1 drugs for weight loss in 2023, a survey from the International Foundation of Employee Benefit Plans found.

In 2023, 34% of employers surveyed covered GLP-1 drugs for weight loss, and 57% covered the drugs to treat Type 2 diabetes. The number of employers covering the cost of the drugs for weight loss increased from 28% in 2022.

The nonprofit educational platform’s survey, published June 13, polled 279 large employers.

The average cost of GLP-1 drugs as a share of employers’ total healthcare costs rose to 8.9% in 2023, up from 6.9% in 2022. The majority of employers surveyed, 85%, reported relying on utilization management to control costs. Most employers covering...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Employer, Insurance, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
The Pandemic Proved That Remote Leadership Works
More than 65 Organizations Call on Workplaces to Provide Comprehensive Obesity Care Coverage
The state of AI: How organizations are rewiring to capture value
To reduce healthcare costs, address chronic conditions
Why Leaders Must Rethink Customer Experience Amid Continued AI Investment

Share This Article